Skip to main content
Equibles
OMCL logo

OMCL · Omnicell, Inc.

Track OMCL — free

Use OMCL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about OMCL

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$33.08 -0.33 (-0.99%) At close · Aug 28
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.52B
Shares
45.61M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$33.08 Open$33.52 Day$32.87–33.76 52W close$29.46–51.39 Avg vol 30d795K Short int3.4M · 7.4% float · 4.8d Short vol56% Last earningsJul 30, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Oct 30, 2026 Est · unconfirmed · in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 5, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.4 · calm Equity put/call 0.62
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −19%
      below
      Price vs 50-day avg −17%
      below
      RSI (14) 31
      neutral
      MACD trend Negative
      52-week position 17%
      mid-range
      Momentum
      relative strength
      Very Weak
      1-month return −6%
      trailing
      6-month return −17%
      trailing
      YTD return −27%
      this year
      Relative strength −30%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $40 › 200d $41 — 200d above 50d
      Institutional flow Accumulating
      +12% holders QoQ · +59 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      7.38% of float · ▼ -2.9% MoM · 4.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      307 holders — near 3-yr high, broad support
      Squeeze score 56
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +10%
      Y/Y
      Gross margin 64%
      contracting
      EPS growth −85%
      Y/Y
      Free cash flow $86.9M
      Valuation P/E 39.8
      in line
      Buyback $62.1M
      remaining
      Balance sheet $77.2M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 51%
      annualized · 1-yr
      Max drawdown −37%
      past year
      ATR 4.3%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 8 of last 8
      Latest guidance · from the 8-K filed Jul 30, 2026
      2026
      Product Bookings $425M – $560M
      Annual Recurring Revenue $660M – $680M
      Total Revenues $1.23B – $1.25B
      prior FY $1.18B midpoint +4.2% Y/Y
      Product Revenues $690M – $700M
      Technical Services Revenues $267M – $272M
      SaaS and Expert Service Revenues $268M – $273M
      Service Revenues $535M – $545M
      Non-GAAP EBITDA Non-GAAP $175M – $185M
      Non-GAAP Earnings Per Share Non-GAAP $2.15 – $2.30
      Q3 2026
      Total Revenues Initiated $301M – $307M
      prior qtr $312.21M midpoint −2.6% QoQ
      Product Revenues Initiated $169M – $172M
      Service Revenues Initiated $132M – $135M
      Non-GAAP EBITDA Non-GAAP Initiated $32M – $37M
      Non-GAAP Earnings Per Share Non-GAAP Initiated $0.35 – $0.43
      Prior guidance period ended · from the 8-K filed Apr 28, 2026
      Total Revenues · Q2 2026 $307M – $313M
      Service Revenues · Q2 2026 $133M – $136M
      Product Revenues · Q2 2026 $174M – $177M
      Non-GAAP EBITDA · Q2 2026 $37M – $42M
      Non-GAAP Earnings Per Share · Q2 2026 $0.40 – $0.48
      Guided vs delivered · last 8 settled
      Total Revenues Q2 2026
      guided $307M – $313M
      $312.21M In line
      Total Revenues Q4 2025
      guided $306M – $316M
      $313.98M In line
      Total Revenues 2025
      guided $1.18B – $1.19B
      $1.18B In line
      Total Revenues Q3 2025
      guided $290M – $300M
      $310.63M Beat +5.3%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Sell
      3 · 3 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −19% Bearish
      Price vs 50-day avg
      −17% Bearish
      RSI (14)
      31 Neutral
      MACD trend
      Negative Bearish
      52-week position
      17% Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $40 › 200d $41 — 200d above 50d
      Institutional flow Accumulating
      +12% holders QoQ · +59 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      7.38% of float · ▼ -2.9% MoM · 4.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      307 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $29 Now $33 · 17% Range high $51
      vs 200-day avg -19% vs 50-day avg -17%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Non-GAAP product gross profit non-GAAP 92.06M Three Months Ended June 30, 2026 —
      GAAP → non-GAAP reconciliation
      GAAP GAAP product gross profit 89.39M
      +708K Share-based compensation expense
      +332K Amortization of acquired intangibles
      +1.63M Professional Services restructuring
      = Non-GAAP product gross profit 92.06M
      Availability under revolving credit facility $350M As of March 31, 2026 —
      Cash flows provided by operating activities $55M first quarter of 2026 —
      Annual Recurring Revenue 635.56M December 31, 2025 —
      Long-term product backlog 205.15M December 31, 2025 —
      Non-GAAP net income per share - diluted non-GAAP $1.62 Year Ended December 31, 2025 —
      GAAP → non-GAAP reconciliation
      GAAP GAAP net income (loss) per share - diluted $0.04
      +$0.96 Share-based compensation expense
      +$0.46 Amortization of acquired intangibles
      +$0.02 Acquisition-related expenses
      +$0.06 EnlivenHealth restructuring
      +$0.08 RDS restructuring, net of reversals
      +$0.06 Legal and regulatory expenses
      +$0.02 Management severance costs
      +$0.02 Executives transition costs
      +$0.06 Amortization of debt issuance costs
      +$0 Gain on extinguishment of convertible senior notes, net
      -$0.16 Tax effect of the adjustments above (a)
      = Non-GAAP net income per share - diluted $1.62
      Non-GAAP operating expenses as a % of total revenues non-GAAP 36.6% Year Ended December 31, 2025 —
      Product bookings 535M the year ended December 31, 2025 —
      Short-term product backlog 435.15M December 31, 2025 —
      Total non-GAAP net income non-GAAP 75M the year ended December 31, 2025 —
      Total product backlog 640.3M December 31, 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      OMCL
      Omnicell, Inc.
      this stock
      		$1.52B -27.0% +10.5% 39.8 7.4%
      VEEV
      Veeva Systems Inc
      		 $44.80B +23.9% +28.1% 45.3 3.6%
      PMDIY
      Pro Medicus Ltd./ADR
      		 $13.02B -24.9% — — 0.0%
      BTSG
      BrightSpring Health Services, Inc.
      		 $11.70B +57.9% +28.2% 35.8 4.5%
      TEM
      Tempus AI, Inc.
      		 $11.56B +8.5% +83.4% — 16.6%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      307
      % held
      106.1%
      Net QoQ
      +1.6M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      355
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      3.4M
      Days to cover
      4.8d
      Change
      -100.6K sh
      View
      Short Volume
      Short vol %
      56%
      As of
      Aug 28, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1.7K
      Value
      $64.2K
      As of
      Jul 31, 2026
      View
      Off-Exchange
      Off-exchange %
      45.2%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Sara Jacobs
      Amount
      $50.0K–$100.0K
      Traded
      Apr 9, 2021
      View
      Financials
      Financials
      Revenue (FY)
      $1.2B
      Net income (FY)
      $2.1M
      EPS diluted
      $0.04
      View
      Buybacks
      Authorized · 2 programs
      $125.0M
      Remaining
      $62.1M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 5, 2026
      This year
      9
      View
      Proposed Sales
      Value
      $113.6K
      Shares
      3.1K
      Filed
      Aug 17, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 30, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      OMCL -7.0% -6.5% -17.0% -6.5% -27.0%
      SPY +0.5% +3.0% +13.4% +3.0% +12.8%
      vs SPY -7.5% -9.5% -30.4% -9.5% -39.8%

      Capital returns

      Buyback programs · 2 active · as of Jun 30, 2025
      Authorized (total)
      $125.00M
      Spent (derived)
      $62.90M
      Remaining
      $62.10M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 926326 CUSIP 68213N109 13F (30d) 268 filings 256 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)